Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial.
Yves DauvilliersColin ShapiroGeert MayerGert Jan LammersHelene EmsellemGiuseppe PlazziDan ChenLawrence P CarterLawrence LeeJed BlackMichael J ThorpyPublished in: CNS drugs (2021)
ClinicalTrials.gov NCT02348593. 28 January 2015.